Trial intelligence / Profile preview

Intranasal Live Attenuated Influenza Vaccine in Children and Adolescents

CTR20160609Phase 2Completed

Sponsor
Changchun BCHT Biotechnology Co.
Start
Sep 2016
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 2 trial of live attenuated influenza vaccine in influenza, sponsored by Changchun BCHT Biotechnology Co.. Started Sep 2016; status: completed.

02

Drugs

live attenuated influenza vaccine
03

Conditions

influenza

Beyond the preview

Go deeper on CTR20160609.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20160609.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call